Profil
Melita Sun Jung currently works at Terns Pharmaceuticals, Inc., as Chief Business Officer from 2024.
Ms. Jung also formerly worked at Adamas Pharmaceuticals LLC, as Senior Director-Corporate Development from 2014 to 2017, Sangamo Therapeutics, Inc., as Head-Business Development from 2017 to 2021, Ascendancy Healthcare, Inc., as Vice President-Business Development from 2012 to 2014, and Structure Therapeutics, Inc., as Chief Business Officer.
Ms. Jung received her undergraduate degree from the University of California, Berkeley.
Postes actifs de Melita Jung
| Sociétés | Poste | Début |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 22/04/2024 |
Anciens postes connus de Melita Jung
| Sociétés | Poste | Fin |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
| ADAMAS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2017 |
Ascendancy Healthcare, Inc.
Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Engages in the commercialization of pharmaceutical products | Corporate Officer/Principal | 01/05/2014 |
| STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | - |
Formation de Melita Jung
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendancy Healthcare, Inc.
Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Engages in the commercialization of pharmaceutical products | Health Technology |
Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
















